• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Optum Rx to Modernize Pharmacy Payment Models

    3/20/25 7:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email

    Rising prices set by pharmaceutical companies are causing pharmacies across the United States to pay more for many drugs, impacting their ability to maintain high-quality care for patients.

    Effective immediately and with full implementation by January 2028, Optum Rx will align payment models more closely to the costs pharmacies may face due to manufacturer pricing actions. This change will positively impact Optum Rx non-affiliated network pharmacies, including the more than 24,000 independent, community pharmacies we serve. These cost-based payment models will also provide more consistently affordable experiences for consumers.

    With this change, Optum Rx is addressing a legacy, industry-wide model that was originally designed to help promote the use of affordable generics. Effective generic adoption is now quite strong, and increasingly, more high-cost branded drugs are entering the market, raising costs for pharmacies. Addressing this imbalance will provide pharmacies with better financial means to stock more medicines, which will alleviate drug shortages, improve access to medications and deliver a better experience for consumers.

    "Pharmacies and pharmacists provide important care to patients, and we recognize that increasing drug prices make it hard for them to afford needed medicines, especially independent and community pharmacies," said Patrick Conway, M.D., chief executive officer of Optum Rx. "This move will help correct imbalances in how pharmacies are paid for brand and generic drugs and will ensure greater access to medicines for patients across the country."

    Epic Pharmacy Network, Inc. (EPN), a Pharmacy Services Administrative Organization representing over 1,000 independent pharmacies across the U.S., has partnered with Optum Rx to pursue a cost-based reimbursement model.

    "Our pharmacists are critical partners in care and often the most consistent health care provider for the patients and communities they serve," said Bretta Grinsteinner, EPN. "This move by Optum Rx is a significant step forward in changing the reimbursement model for our pharmacies, who continue to struggle with the rising costs of medications. EPN is committed to working alongside Optum Rx in their efforts to address reimbursement issues that plague pharmacies nationwide."

    In parallel, Optum Rx will similarly transition client arrangements - such as employer and health plan customers - to ensure transparency and greater alignment to drug costs. We have already started implementing these changes, with the goal of completing full implementation by January 1, 2028.

    These changes build on our recent commitment to pass through 100% of drug rebate discounts negotiated with pharmaceutical manufacturers to clients by January 1, 2028. Combined, these moves make Optum Rx the first comprehensive, transparent pharmacy services company that passes through savings to its clients and consumers.

    Supporting Pharmacies Across the U.S.

    Optum Rx has been working to ensure pharmacies are paid fairly and offering solutions to improve operational efficiency and reduce administrative burden so they can spend more time caring for patients. Some of these efforts include:

    • Reimbursing pharmacists for connecting their underserved patients to services that address basic needs such as food, nutrition, transportation, housing and baby supplies. Key areas of focus include maternal wellness and meeting health care needs in urban and rural communities where there are not many pharmacies.
    • Supporting independent pharmacists by paying them for services such as counseling and medication management aimed at improving patient outcomes.
    • Enhancing pharmacy digital capabilities to easily access claims and payment data, ease administrative burdens and manage revenue.
    • Removing retroactive recoupment ("clawbacks") for pharmacies.
    • Offering predictive analytics and other tools to further reduce administrative burden and allow more time to focus on patient care.

    About Optum

    Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 210,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group. For more information, visit www.Optum.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250320962927/en/

    Media Contact: [email protected]

    Get the next $UNH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    10/14/2025$406.00Buy
    Goldman
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    7/30/2025$400.00 → $325.00Outperform
    Oppenheimer
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    More analyst ratings

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UnitedHealth Group Announces Earnings Release Date

    UnitedHealth Group (NYSE:UNH) will release its full year 2025 financial results and provide 2026 financial guidance on Tuesday, January 27, 2026, before the market opens, and will host a teleconference at 8:00 a.m. ET with analysts and investors. This call will be webcast on the Investor Relations page of the company's website (www.unitedhealthgroup.com). The replay will be available through February 10 on the website. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care

    12/12/25 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    Scott Gottlieb, M.D., Joins UnitedHealth Group Board of Directors

    Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE:UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regulations to help foster medical innovation, promote competition in the pharmaceutical market, confront the opioid epidemic and curb youth tobacco use. "Scott has had an exceptional health care career in both the public and private sectors," said Stephen J. Hemsley, UnitedHealth Group's CEO and executive board chairman.

    11/18/25 6:45:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on December 16, 2025, to all shareholders of record of UNH common stock as of the close of business December 8, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of hea

    11/7/25 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    SEC Filings

    View All

    UnitedHealth Group Incorporated filed SEC Form 8-K: Leadership Update

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    11/21/25 5:20:04 PM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    11/13/25 4:02:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form S-8 filed by UnitedHealth Group Incorporated

    S-8 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    11/13/25 6:07:17 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Gottlieb Scott claimed no ownership of stock in the company (SEC Form 3)

    3 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    11/26/25 4:08:30 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Garcia Paul R was granted 260 shares, increasing direct ownership by 9% to 3,021 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    10/3/25 4:20:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Mcnabb Frederick William Iii was granted 289 shares, increasing direct ownership by 2% to 14,341 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    10/3/25 4:19:59 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded UnitedHealth from Buy to Hold and set a new price target of $333.00

    10/29/25 7:53:31 AM ET
    $UNH
    Medical Specialities
    Health Care

    Goldman initiated coverage on UnitedHealth with a new price target

    Goldman initiated coverage of UnitedHealth with a rating of Buy and set a new price target of $406.00

    10/14/25 8:54:29 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded UnitedHealth from Neutral to Underperform and set a new price target of $198.00

    7/31/25 7:58:50 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:47 PM ET
    $UNH
    Medical Specialities
    Health Care

    CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 12:28:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Financials

    Live finance-specific insights

    View All

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on December 16, 2025, to all shareholders of record of UNH common stock as of the close of business December 8, 2025. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of hea

    11/7/25 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Reports Third Quarter 2025 Results and Raises Full Year 2025 Earnings Outlook

    Third Quarter 2025 Revenues of $113.2 Billion Grew 12% Year-Over-Year Third Quarter Earnings of $2.59 Per Share, Adjusted Earnings $2.92 Per Share Cash Flows from Operations were $5.9 Billion, or 2.3x Net Income Raises Full Year 2025 Earnings Outlook to at least $14.90 Per Share; Adjusted Earnings of at least $16.25 Per Share UnitedHealth Group (NYSE:UNH) reported third quarter 2025 results, reflecting the continued execution on its performance agenda, refocus on its mission and culture, and return to sustained growth. "We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter reflect so

    10/28/25 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    AM Best Downgrades Credit Ratings of UnitedHealth Group Incorporated and Its Subsidiaries; Revises Outlooks to Stable

    AM Best has downgraded the Long-Term Issuer Credit Ratings (Long-Term ICR) to "a-" (Excellent) from "a" (Excellent) and the Long and Short-Term Issue Credit Ratings (Long-Term IR; Short-Term IR) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). Concurrently AM Best has downgraded the Financial Strength Rating (FSR) to A (Excellent) from A+ (Superior) and the Long-Term ICRs to "a+" (Excellent) from "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. The outlook of these Credit Ratings (ratings) has been revised to stable from negative. (See link below for a detailed listing of

    8/28/25 4:18:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/13/24 5:16:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/24 10:05:20 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/23 12:39:51 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

    5/13/25 5:59:56 PM ET
    $UNH
    Medical Specialities
    Health Care

    Charlie Baker Joins UnitedHealth Group's Board of Directors

    UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

    11/3/23 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care